Fiche taxotere
WebTAXOTERE is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. TAXOTERE in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. 1.2 Non-small Cell Lung Cancer TAXOTERE is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for ...
Fiche taxotere
Did you know?
WebTaxotere (R) is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Taxotere (R) in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Non-Small Cell Lung Cancer (NSCLC) WebEmail Alerts. Docetaxel (Taxotere, Sanofi-Aventis) has substantial activity when administered alone in patients with recurrent or incurable disease. 12,13 In phase 1 and …
WebTAXOTERE ® (Docétaxel) Ce médicament pourra être administré en perfusion intraveineuse une fois par semaine ou toutes les 3 semaines avec une durée moyenne … WebApr 15, 2024 · The most recent is the 2015 black box warning about the risk of permanent alopecia. In 2015, the U.S. Food and Drug Administration (FDA) required Sanofi-Aventis to update labels on all products containing the drug docetaxel. The updated label included a black box warning that Taxotere included a risk for permanent hair loss, or alopecia.
WebTaxotere is the trade name for docetaxel. In some cases, health care professionals may use the trade name taxotere when referring to the generic drug name docetaxel. Drug type: Docetaxel is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "plant alkaloid," a "taxane" and an "antimicrotubule ... WebEuropean Medicines Agency
WebOncoNormandie - Réseau Régional de Cancérologie
WebJan 24, 2014 · Patient preference (Taxotere versus Jevtana) assessed by a single question after completion of the second period of chemotherapy. Primary outcome measure will … relational actsWebTAXOTERE is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant … relational accountabilityWebDocetaxel is a prescription chemotherapy drug used to treat different kinds of cancer, including cancers of the breast, prostate, stomach, head and neck cancers, and non-small-cell lung cancer. ... production machine magazineWebJan 12, 2024 · Taxotere en association à la doxorubicine et au cyclophosphamide est indiqué dans le traitement adjuvant du : cancer du sein opérable, chez des patients … production machine operator job descriptionWebTAXOTERE is a microtubule inhibitor indicated for: Breast Cancer (BC) : single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as... relational advertisingWebTAXOTERE (docetaxel) Injection Concentrate is a clear yellow to brownish-yellow viscous solution. TAXOTERE is sterile, non-pyrogenic, and is available in single-dose vials containing 20 mg (0.5 mL) or 80 mg (2 mL) docetaxel (anhydrous). Each mL contains 40 mg docetaxel (anhydrous) and 1040 mg polysorbate 80. relational acumen meaningWebLes centres de recherche préventive : les contributions à la mise à niveau du personnel de la santé publique par la formation. Le processus consultatif sur l'asthme : une approche … relational advisors